Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 41.6431.4190.4644.6521.42

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 41.64 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202541.64
Mar202431.41
Mar202390.46
Mar202244.65
Mar202121.42

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 41.64
32.57
Mar2024 31.41
-65.28
Mar2023 90.46
102.60
Mar2022 44.65
108.45
Mar2021 21.42 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹766.5 Cr -1.8% -16.2% 115.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-1.8%

-16.2%

115.3%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses